Kiniciti
Founded 2020 · 8 employees on LinkedIn · 3 known investors
Find your way into Kiniciti
89 people in our graph share verified history with the Kiniciti team — schools, employers, funds. One of them is your warm intro.
Laura Sageunlockedknows Geoffrey Glass · together at University of Arizona (overlapped)
×11knows the team · via Occidental College
Kiniciti is a platform company that operates cell and gene therapy-focused life science businesses, including Cellistic for iPSC-based manufacturing technologies and Ncardia for human iPSC products and drug discovery services. The company serves therapeutic developers and pharmaceutical companies seeking scalable cell therapy manufacturing and drug discovery solutions.
Founders & leadership
Kiniciti was founded in 2020 by Geoffrey Glass.
GG
Geoffrey GlassinFounding CEOGeoffrey Glass is founding CEO of Kiniciti, a platform company operating cell and gene therapy-focused life science businesses including Cellistic and Ncardia. He has extensive background in pharmaceutical and biotechnology product and services sectors.
Investors · 3
Founder mafia
2 people who came through Kiniciti went on to found or lead other companies.
In the news
Frequently asked questions
- What does Kiniciti do?
- Kiniciti is a platform company that operates cell and gene therapy-focused life science businesses, including Cellistic for iPSC-based manufacturing technologies and Ncardia for human iPSC products and drug discovery services. The company serves therapeutic developers and pharmaceutical companies seeking scalable cell therapy manufacturing and drug discovery solutions.
- Who founded Kiniciti?
- Kiniciti was founded by Geoffrey Glass in 2020.
- Who are Kiniciti's investors?
- Kiniciti's investors include BIOSPRING PARTNERS, Welsh, Carson, Anderson & Stowe, WCAS.